219 related articles for article (PubMed ID: 34853378)
1. Therapeutic potential of TRPM8 antagonists in prostate cancer.
Di Donato M; Ostacolo C; Giovannelli P; Di Sarno V; Monterrey IMG; Campiglia P; Migliaccio A; Bertamino A; Castoria G
Sci Rep; 2021 Dec; 11(1):23232. PubMed ID: 34853378
[TBL] [Abstract][Full Text] [Related]
2. New TRPM8 blockers exert anticancer activity over castration-resistant prostate cancer models.
Di Sarno V; Giovannelli P; Medina-Peris A; Ciaglia T; Di Donato M; Musella S; Lauro G; Vestuto V; Smaldone G; Di Matteo F; Bifulco G; Castoria G; Migliaccio A; Fernandez-Carvajal A; Campiglia P; Gomez-Monterrey I; Ostacolo C; Bertamino A
Eur J Med Chem; 2022 Aug; 238():114435. PubMed ID: 35598411
[TBL] [Abstract][Full Text] [Related]
3. TRPM8 channel as a novel molecular target in androgen-regulated prostate cancer cells.
Asuthkar S; Velpula KK; Elustondo PA; Demirkhanyan L; Zakharian E
Oncotarget; 2015 Jul; 6(19):17221-36. PubMed ID: 25980497
[TBL] [Abstract][Full Text] [Related]
4. Tetrahydroisoquinoline-Derived Urea and 2,5-Diketopiperazine Derivatives as Selective Antagonists of the Transient Receptor Potential Melastatin 8 (TRPM8) Channel Receptor and Antiprostate Cancer Agents.
De Petrocellis L; Arroyo FJ; Orlando P; Schiano Moriello A; Vitale RM; Amodeo P; Sánchez A; Roncero C; Bianchini G; Martín MA; López-Alvarado P; Menéndez JC
J Med Chem; 2016 Jun; 59(12):5661-83. PubMed ID: 27232526
[TBL] [Abstract][Full Text] [Related]
5. Identification of a natural compound, sesamin, as a novel TRPM8 antagonist with inhibitory effects on prostate adenocarcinoma.
Sui Y; Li S; Zhao Y; Liu Q; Qiao Y; Feng L; Li S
Fitoterapia; 2020 Sep; 145():104631. PubMed ID: 32439453
[TBL] [Abstract][Full Text] [Related]
6. Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro-apoptotic effects and underlying mechanisms.
De Petrocellis L; Ligresti A; Schiano Moriello A; Iappelli M; Verde R; Stott CG; Cristino L; Orlando P; Di Marzo V
Br J Pharmacol; 2013 Jan; 168(1):79-102. PubMed ID: 22594963
[TBL] [Abstract][Full Text] [Related]
7. Blockade of TRPM8 activity reduces the invasion potential of oral squamous carcinoma cell lines.
Okamoto Y; Ohkubo T; Ikebe T; Yamazaki J
Int J Oncol; 2012 May; 40(5):1431-40. PubMed ID: 22267123
[TBL] [Abstract][Full Text] [Related]
8. Menthol inhibits the proliferation and motility of prostate cancer DU145 cells.
Wang Y; Wang X; Yang Z; Zhu G; Chen D; Meng Z
Pathol Oncol Res; 2012 Oct; 18(4):903-10. PubMed ID: 22437241
[TBL] [Abstract][Full Text] [Related]
9. TRPM8-androgen receptor association within lipid rafts promotes prostate cancer cell migration.
Grolez GP; Gordiendko DV; Clarisse M; Hammadi M; Desruelles E; Fromont G; Prevarskaya N; Slomianny C; Gkika D
Cell Death Dis; 2019 Sep; 10(9):652. PubMed ID: 31501416
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological and functional properties of TRPM8 channels in prostate tumor cells.
Valero M; Morenilla-Palao C; Belmonte C; Viana F
Pflugers Arch; 2011 Jan; 461(1):99-114. PubMed ID: 21052713
[TBL] [Abstract][Full Text] [Related]
11. Androgen regulated TRPM8 expression: a potential mRNA marker for metastatic prostate cancer detection in body fluids.
Bai VU; Murthy S; Chinnakannu K; Muhletaler F; Tejwani S; Barrack ER; Kim SH; Menon M; Veer Reddy GP
Int J Oncol; 2010 Feb; 36(2):443-50. PubMed ID: 20043080
[TBL] [Abstract][Full Text] [Related]
12. A Small Peptide Targeting the Ligand-Induced Androgen Receptor/Filamin a Interaction Inhibits the Invasive Phenotype of Prostate Cancer Cells.
Di Donato M; Giovannelli P; Barone MV; Auricchio F; Castoria G; Migliaccio A
Cells; 2021 Dec; 11(1):. PubMed ID: 35011576
[TBL] [Abstract][Full Text] [Related]
13. Prospects for prostate cancer imaging and therapy using high-affinity TRPM8 activators.
Beck B; Bidaux G; Bavencoffe A; Lemonnier L; Thebault S; Shuba Y; Barrit G; Skryma R; Prevarskaya N
Cell Calcium; 2007 Mar; 41(3):285-94. PubMed ID: 16949669
[TBL] [Abstract][Full Text] [Related]
14. Evidence for specific TRPM8 expression in human prostate secretory epithelial cells: functional androgen receptor requirement.
Bidaux G; Roudbaraki M; Merle C; Crépin A; Delcourt P; Slomianny C; Thebault S; Bonnal JL; Benahmed M; Cabon F; Mauroy B; Prevarskaya N
Endocr Relat Cancer; 2005 Jun; 12(2):367-82. PubMed ID: 15947109
[TBL] [Abstract][Full Text] [Related]
15. Identification of novel androgen receptor degrading agents to treat advanced prostate cancer.
Wu H; Ren J; Zhao L; Li Z; Ye W; Yang Y; Wang J; Bian J
Eur J Med Chem; 2021 May; 217():113376. PubMed ID: 33756125
[TBL] [Abstract][Full Text] [Related]
16. Assessment of the TRPM8 inhibitor AMTB in breast cancer cells and its identification as an inhibitor of voltage gated sodium channels.
Yapa KTDS; Deuis J; Peters AA; Kenny PA; Roberts-Thomson SJ; Vetter I; Monteith GR
Life Sci; 2018 Apr; 198():128-135. PubMed ID: 29496495
[TBL] [Abstract][Full Text] [Related]
17. PSA reduces prostate cancer cell motility by stimulating TRPM8 activity and plasma membrane expression.
Gkika D; Flourakis M; Lemonnier L; Prevarskaya N
Oncogene; 2010 Aug; 29(32):4611-6. PubMed ID: 20531306
[TBL] [Abstract][Full Text] [Related]
18. Evidence that TRPM8 is an androgen-dependent Ca2+ channel required for the survival of prostate cancer cells.
Zhang L; Barritt GJ
Cancer Res; 2004 Nov; 64(22):8365-73. PubMed ID: 15548706
[TBL] [Abstract][Full Text] [Related]
19. Discovery and biological characterization of a novel series of androgen receptor modulators.
Zhou C; Wu G; Feng Y; Li Q; Su H; Mais DE; Zhu Y; Li N; Deng Y; Yang D; Wang MW
Br J Pharmacol; 2008 May; 154(2):440-50. PubMed ID: 18414397
[TBL] [Abstract][Full Text] [Related]
20. The TRPM8 protein is a testosterone receptor: I. Biochemical evidence for direct TRPM8-testosterone interactions.
Asuthkar S; Elustondo PA; Demirkhanyan L; Sun X; Baskaran P; Velpula KK; Thyagarajan B; Pavlov EV; Zakharian E
J Biol Chem; 2015 Jan; 290(5):2659-69. PubMed ID: 25480783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
